YBX1 and melanoma: The findings of Schmid et al. (2013) suggested YB-1 could act as a mediator of Melanoma inhibitory activity (MIA)/cartilage-derived retinoic acid-sensitive protein (CD/RAP) dependent chondrogenesis.